chemotherapy induced oral mucositis. Oral mucositis (ulcerative) due to antineoplastic therapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients underwent chemotherapy process, due to various types of malignancies, without concurrent radiotherapy mucositis grade 2 or 3 (WHO criteria) prognosis for at least 6 months signing the consent form
Exclusion criteria
Exclusion criteria: Patients with mucositis of grade 1 or 4 sign of causing side effects (such as sensitivity to phenytoin) lack of patient cooperation or trend to complete the treatment process systemic diseases with oral mucositis (such as connective tissue diseases and Sjogren syndrome)or interfering with healing process of tissues (such as diabetes) smoking and alcohol consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grade of oral mucositis and pain. Timepoint: before intervention, 1 and 2 weeks after intervention. Method of measurement: WHO grading and Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences